Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Countries

 

Interview: Simon Turton, Gensmile

At the height of Covid, NHS-focussed dental practices calmly told HBI that their revenues were covered by government payments, and their dental activity targets had been slashed or temporarily abandoned. It was a good time to have a strong NHS patient bias. HBI speaks to Simon Turton, CEO and co-founder of UK dental chain Gensmile and panellist at HBI 2022, to hear how the tide may be turning in favour of private funding.

Medica returned to form in 2021 thanks to elective care rebound

After a rough 2020, the UK’s largest teleradiology company, Medica, achieved strong results in 2021, with sales reaching £62m (a 68% increase from 2020 and a 33% increase from 2019), and a healthy 19.5% operating margin. We speak to CEO Stuart Quin to find out more.

€4bn Inovie looking for majority shareholder

French lab group Inovie is looking for a new majority stakeholder off a €4bn+ enterprise value, HBI hears. Inovie is currently working with financial advisers to determine interest from potential buyers.

Interview: Dirk Knüppel, Meine Radiologie

Imaging and radiology is hot at the moment - especially in Germany. The next five years are going to see a huge amount of consolidation according to Dirk Knüppel, CEO at EQT-backed Meine Radiologie & Blikk Holding (MRBH) and HBI 2022 panellist. HBI caught up with him to find out more about his group's plans to expand across Europe.

New report says the digital revolution will be painful – especially for staff

Healthcare digitisation will change the nature of what it means to be a doctor or nurse, undermining many employees' sense of work satisfaction, according to a new report by Netherlands-based medical research publisher Elsevier. HBI speaks with Charles Alessi, one of the report’s authors, to find out more.

Turkish groups look for lira depreciation workarounds

The Turkish Lira has been consistently depreciating, losing three-quarters of its US dollar value in the last five years. HBI speaks with an operator source, as well as consultants and operators from Turkey, to find out their strategy to hedge against a worsening exchange rate.

Most major healthcare stocks see fall in Q1

Eleven out of 14 major listed healthcare groups saw their share values decrease in the first quarter of 2022, in spite of (or perhaps in some cases because of) Covid restrictions being lifted in multiple countries.

KKR set to acquire IVI-RMA

Multiple sources say US-based buyout specialist KKR is close to closing a deal to buy Spain-based global fertility player IVI-RMA, the largest group in the sector by revenue.

Find Us